OP
EW icon

ORG Partners’s Edwards Lifesciences EW Stock Holding History

ORG Partners’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$9.89K Buy
116
+11
+10% +$903 ﹤0.01% 1014
2025
Q3 		$8.16K Buy
105
+34
+48% +$2.66K ﹤0.01% 1016
2025
Q2 		$5.47K Sell
71
-79
-53% -$5.89K ﹤0.01% 1035
2025
Q1 		$10.8K Sell
150
-1,047
-87% -$74.9K ﹤0.01% 783
2024
Q4 		$88.6K Buy
1,197
+54
+5% +$3.78K 0.01% 447
2024
Q3 		$75.4K Sell
1,143
-16
-1% -$1.16K 0.01% 440
2024
Q2 		$105K Buy
1,159
+1,065
+1,133% +$94.3K 0.01% 582
2024
Q1 		$8.86K Sell
94
-661
-88% -$55.5K 0.02% 296
2023
Q4 		$57.6K Sell
755
-194
-20% -$13.5K 0.01% 494
2023
Q3 		$65.7K Buy
+949
New +$76.3K 0.02% 480

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

ORG Partners's EW Position: Q4 2025 in Review

ORG Partners increased its Edwards Lifesciences (EW) stake by 10% in Q4 2025, buying an estimated $903 and bringing the position to 116 shares worth $9.89K. The position accounts for ﹤0.01% of the portfolio, ranked #1014.

ORG Partners first reported a position in EW in Q3 2023 and has held it in 10 quarters since. The position peaked at $105K in Q2 2024. 1,313 funds tracked by Wall St. Rank hold EW as of Q4 2025.

  • ORG Partners held 116 shares of Edwards Lifesciences worth $9.89K as of Q4 2025.
  • ORG Partners bought 11 Edwards Lifesciences shares in Q4 2025, an estimated $903.
  • Edwards Lifesciences made up ﹤0.01% of ORG Partners's portfolio in Q4 2025, its #1014 holding.
  • ORG Partners first reported a position in Edwards Lifesciences in Q3 2023 and has held it in 10 quarters since.
  • ORG Partners's Edwards Lifesciences position peaked at $105K in Q2 2024.
  • 1,313 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2025.

Based on ORG Partners's 13F filing for Q4 2025, filed 14 Jan 2026.